Abstract
Lipoprotein nanoparticles delivering an inflammation-targeting signalling inhibitor reduce vascular inflammation in atherosclerotic mice.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 269-270 |
| Number of pages | 2 |
| Journal | Nature Biomedical Engineering |
| Volume | 2 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 1 2018 |
ASJC Scopus subject areas
- Biotechnology
- Bioengineering
- Medicine (miscellaneous)
- Biomedical Engineering
- Computer Science Applications
Fingerprint
Dive into the research topics of 'Inflammation-targeted vascular nanomedicine'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS